New drug NBX-100 tested in healthy people for safety
Knowledge-focused
Not yet recruiting
This early-stage study tests the safety and how the body processes a new drug called NBX-100 in 8 healthy adults aged 21-50. Participants receive four weekly doses and have frequent check-ups and psychological support visits. The goal is to gather safety and drug-level informatio…
Phase: PHASE1 • Sponsor: Neurala Biosciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC